Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2005; 11(41): 6429-6432
Published online Nov 7, 2005. doi: 10.3748/wjg.v11.i41.6429
Published online Nov 7, 2005. doi: 10.3748/wjg.v11.i41.6429
Table 1 MTT results of transfection groups (n=3, mean ±SD)
| Group | A490nm | P1 |
| pHVP22/F | 0.425 ± 0.065 | >0.05 |
| pHVP22/U | 0.465 ± 0.050 | >0.05 |
| pHVP22/D | 0.410 ± 0.075 | >0.05 |
| pHVP22/M | 0.438 ± 0.042 | >0.05 |
| pHBc | 0.413 ± 0.063 | >0.05 |
| pcDNA3.1(–) | 0.430 ± 0.065 | >0.05 |
| MOCK | 0.423 ± 0.058 | >0.05 |
- Citation: Yi J, Gong WD, Wang L, Ling R, Chen JH, Yun J. VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication. World J Gastroenterol 2005; 11(41): 6429-6432
- URL: https://www.wjgnet.com/1007-9327/full/v11/i41/6429.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i41.6429